Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CVS.DE
STRONG BUYCVS Health Corporation · Healthcare · United States · $134.2B · Avg Vol: $38K/d
COMPANY DESCRIPTION
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management...
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 322.5B | 357.8B | 372.8B | 402.1B | 7.6% | 405.6B | 409.2B | 426.5B | 3.0% |
| EPS | 3.29 | 6.49 | 3.67 | 1.40 | -24.8% | 2.28 | — | — | — |
| Shares | 1.8B | 1.8B | 1.8B | 1.8B | +1.6% | — | — | — | — |
| Debt | 70.7B | 79.4B | 82.9B | 80.0B | 4.2% | 78.3B | — | — | — |
| Equity | 71.5B | 76.5B | 75.6B | 75.2B | 1.7% | — | — | — | — |
| Op CF | 16.2B | 13.4B | 9.1B | 10.6B | -13.0% | 10.3B | — | — | — |
| Inv CF | -5.0B | -20.9B | -7.6B | -5.9B | — | — | — | — | — |
| Fin CF | -10.5B | 2.7B | -1.1B | -4.9B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CVS.DE are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CVS.DE | CVS Health Corporation(you) | $134.2B | 93 | STRONG BUY |
| ELV | Elevance Health, Inc. | $85.8B | 92 | STRONG BUY |
| CI | The Cigna Group | $74.8B | 96 | STRONG BUY |
| UNH.MX | UnitedHealth Group Incorporated | $385.6B | 98 | STRONG BUY |
| HUM | Humana Inc. | $46.1B | 86 | STRONG BUY |
| CNC | Centene Corporation | $32.5B | 92 | STRONG BUY |
| MOH | Molina Healthcare, Inc. | $12.0B | 84 | STRONG BUY |
| OSCR | Oscar Health, Inc. | $9.0B | 89 | STRONG BUY |
| PGNY | Progyny, Inc. | $2.2B | 97 | STRONG BUY |
| ALHC | Alignment Healthcare, Inc. | $4.8B | 62 | HOLD |
Peer medians: ROE 2.7% · P/E 22.8x · Gross margin 47.5%